Global Cell Therapy Market Size, Share, Trends and Forecast 2022-2030

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
Industry Insights

The global Cell Therapy market size is projected to reach US$ 250460 million by 2028, from US$ 101000 million in 2021, at a CAGR of 13.5% during 2022-2028.

The classification of Cell Therapy includes Stem Cell therapy and Non-Stem Cell therapy, and the revenue proportion of Stem Cell therapy in 2019 is about 98.76%.

Cell Therapy is widely used in Hospital, Clinics and Other. The most proportion of Cell Therapy is Hospital, and the proportion in 2019 is about 77.2%.

North Americas is the largest consumption place, with a consumption market share nearly 43.65% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 35.41%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Therapy market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Therapy market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Cell Therapy market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Cell Therapy Breakdown Data by Type

Stem Cell

Non-Stem Cell

Cell Therapy Breakdown Data by Application

Hospital

Clinic

Regional Analysis

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Gilead Sciences

Novartis

Osiris

Vericel Corporation

Vcanbio

Fujifilm Cellular Dynamics

JCR Pharmaceuticals

Beike Biotechnology

Golden Meditech

Guanhao Biotech

1 Report Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Stem Cell

1.2.3 Non-Stem Cell

1.3 Market by Application

1.3.1 Global Cell Therapy Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Clinic

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Cell Therapy Market Perspective (2017-2028)

2.2 Cell Therapy Growth Trends by Region

2.2.1 Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Cell Therapy Historic Market Size by Region (2017-2022)

2.2.3 Cell Therapy Forecasted Market Size by Region (2023-2028)

2.3 Cell Therapy Market Dynamics

2.3.1 Cell Therapy Industry Trends

2.3.2 Cell Therapy Market Drivers

2.3.3 Cell Therapy Market Challenges

2.3.4 Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cell Therapy Players by Revenue

3.1.1 Global Top Cell Therapy Players by Revenue (2017-2022)

3.1.2 Global Cell Therapy Revenue Market Share by Players (2017-2022)

3.2 Global Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cell Therapy Revenue

3.4 Global Cell Therapy Market Concentration Ratio

3.4.1 Global Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Revenue in 2021

3.5 Cell Therapy Key Players Head office and Area Served

3.6 Key Players Cell Therapy Product Solution and Service

3.7 Date of Enter into Cell Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cell Therapy Breakdown Data by Type

4.1 Global Cell Therapy Historic Market Size by Type (2017-2022)

4.2 Global Cell Therapy Forecasted Market Size by Type (2023-2028)

5 Cell Therapy Breakdown Data by Application

5.1 Global Cell Therapy Historic Market Size by Application (2017-2022)

5.2 Global Cell Therapy Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Cell Therapy Market Size (2017-2028)

6.2 North America Cell Therapy Market Size by Country (2017-2022)

6.3 North America Cell Therapy Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7 Europe

7.1 Europe Cell Therapy Market Size (2017-2028)

7.2 Europe Cell Therapy Market Size by Country (2017-2022)

7.3 Europe Cell Therapy Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cell Therapy Market Size (2017-2028)

8.2 Asia-Pacific Cell Therapy Market Size by Country (2017-2022)

8.3 Asia-Pacific Cell Therapy Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9 Latin America

9.1 Latin America Cell Therapy Market Size (2017-2028)

9.2 Latin America Cell Therapy Market Size by Country (2017-2022)

9.3 Latin America Cell Therapy Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cell Therapy Market Size (2017-2028)

10.2 Middle East & Africa Cell Therapy Market Size by Country (2017-2022)

10.3 Middle East & Africa Cell Therapy Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11 Key Players Profiles

11.1 Gilead Sciences

11.1.1 Gilead Sciences Company Detail

11.1.2 Gilead Sciences Business Overview

11.1.3 Gilead Sciences Cell Therapy Introduction

11.1.4 Gilead Sciences Revenue in Cell Therapy Business (2017-2022)

11.1.5 Gilead Sciences Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Cell Therapy Introduction

11.2.4 Novartis Revenue in Cell Therapy Business (2017-2022)

11.2.5 Novartis Recent Development

11.3 Osiris

11.3.1 Osiris Company Detail

11.3.2 Osiris Business Overview

11.3.3 Osiris Cell Therapy Introduction

11.3.4 Osiris Revenue in Cell Therapy Business (2017-2022)

11.3.5 Osiris Recent Development

11.4 Vericel Corporation

11.4.1 Vericel Corporation Company Detail

11.4.2 Vericel Corporation Business Overview

11.4.3 Vericel Corporation Cell Therapy Introduction

11.4.4 Vericel Corporation Revenue in Cell Therapy Business (2017-2022)

11.4.5 Vericel Corporation Recent Development

11.5 Vcanbio

11.5.1 Vcanbio Company Detail

11.5.2 Vcanbio Business Overview

11.5.3 Vcanbio Cell Therapy Introduction

11.5.4 Vcanbio Revenue in Cell Therapy Business (2017-2022)

11.5.5 Vcanbio Recent Development

11.6 Fujifilm Cellular Dynamics

11.6.1 Fujifilm Cellular Dynamics Company Detail

11.6.2 Fujifilm Cellular Dynamics Business Overview

11.6.3 Fujifilm Cellular Dynamics Cell Therapy Introduction

11.6.4 Fujifilm Cellular Dynamics Revenue in Cell Therapy Business (2017-2022)

11.6.5 Fujifilm Cellular Dynamics Recent Development

11.7 JCR Pharmaceuticals

11.7.1 JCR Pharmaceuticals Company Detail

11.7.2 JCR Pharmaceuticals Business Overview

11.7.3 JCR Pharmaceuticals Cell Therapy Introduction

11.7.4 JCR Pharmaceuticals Revenue in Cell Therapy Business (2017-2022)

11.7.5 JCR Pharmaceuticals Recent Development

11.8 Beike Biotechnology

11.8.1 Beike Biotechnology Company Detail

11.8.2 Beike Biotechnology Business Overview

11.8.3 Beike Biotechnology Cell Therapy Introduction

11.8.4 Beike Biotechnology Revenue in Cell Therapy Business (2017-2022)

11.8.5 Beike Biotechnology Recent Development

11.9 Golden Meditech

11.9.1 Golden Meditech Company Detail

11.9.2 Golden Meditech Business Overview

11.9.3 Golden Meditech Cell Therapy Introduction

11.9.4 Golden Meditech Revenue in Cell Therapy Business (2017-2022)

11.9.5 Golden Meditech Recent Development

11.10 Guanhao Biotech

11.10.1 Guanhao Biotech Company Detail

11.10.2 Guanhao Biotech Business Overview

11.10.3 Guanhao Biotech Cell Therapy Introduction

11.10.4 Guanhao Biotech Revenue in Cell Therapy Business (2017-2022)

11.10.5 Guanhao Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details